These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6307175)

  • 1. [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1797-800. PubMed ID: 6307175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, Adriamycin and mitomycin-C.
    Al-Idrissi HY; Ibrahim EM; Abdel Satir A; Satti MB; Al-Kasem S; Al-Qurain A
    Hepatogastroenterology; 1985 Feb; 32(1):8-10. PubMed ID: 2985480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
    Ohya T; Kikuchi S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1623-7. PubMed ID: 6191720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma.
    Misra NC; Jaiswal MS; Singh RV; Das B
    Cancer; 1977 Apr; 39(4):1425-9. PubMed ID: 192431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
    Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
    Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
    Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
    Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.
    Obi S; Yoshida H; Toune R; Unuma T; Kanda M; Sato S; Tateishi R; Teratani T; Shiina S; Omata M
    Cancer; 2006 May; 106(9):1990-7. PubMed ID: 16565970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS; Chang HK; Chen JS; Lin YC; Liau CT; Chang WC
    J Gastroenterol; 2004; 39(4):362-9. PubMed ID: 15168248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of chemotherapy in hepatocellular carcinoma with liver cirrhosis].
    Munehisa T; Tajima H; Goto M; Nakata K; Muro T; Kawahara K; Kohno K; Sato A; Furukawa R; Ogino T
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2318-23. PubMed ID: 6314913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumors of the liver].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Nagata T; Aiba K; Domyo M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1955-60. PubMed ID: 6307177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.